I think a lot are underestimating the significance of these partnerships - we now have stability, throughput at the facility, globally leading partners and expertise in both Valens and Cannvalate - which will further open up other BD opportunities no doubt, we have 3 new Novel Cannabinoid products, with clinical potential and pathway to S3 potential, which we did not have before, capital and operational expenditure is now shelved off to Valens and a new significant shareholder in Cannvalate who are now incentivised to increase shareholder value. This could not be a better deal....
- Forums
- ASX - By Stock
- EPN
- Ann: Epsilon Enters Exclusive Partnership with The Valens Company
Ann: Epsilon Enters Exclusive Partnership with The Valens Company, page-29
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EPN (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EPN (ASX) Chart |
Day chart unavailable
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online